Lantern
PrivateLast Round
Growth Equity
Mar 19, 2026
Est. Valuation
$1B
Total Funding Raised
$31M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Lantern operates in Healthcare & Life Sciences and is based in Dallas, Texas. Its latest recorded funding round was a Growth Equity round in March 2026.
Lantern is a specialty care platform that provides services to self-funded employers by connecting members with a curated network of top-performing specialists for surgery, cancer care, and infusion therapies.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Patient Engagement, InsurTech
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lantern Comparables
Compare Lantern with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Empathy | 84% | |
| Elayne | 70% | |
| Betterleave | 70% |
For institutional investors. Book with your work email.
Lantern Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Mar 19, 2026 | ||||
| Secondary | Dec 19, 2023 | ||||
| Growth Equity | Jul 28, 2021 | ||||
| Growth Equity | Oct 27, 2020 | ||||
| Series C | Jan 12, 2016 | ||||
Series A | May 1, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lantern Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Secondary, Growth Equity |
| Morgan Health | Growth Equity |
| Dundon Capital Partners | Growth Equity, Series C |
| Serent Capital | Secondary, Growth Equity |
| TEXO Ventures | Series A, Series C |
| Echo Health Ventures | Growth Equity |
| Insight Partners | Secondary |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2026
Scaling a 200+ Care Advocate contact center.
- Mar 25, 2026
Named to Fast Company's Most Innovative Companies list.
For institutional investors. Book with your work email.
Lantern Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lantern's valuation, stock price, and market status.
Is Lantern a public or private company?
Lantern is a private company.
What is the current stock price of Lantern?
Lantern is a private company, so its shares have no public market price. Caplight tracks Lantern's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lantern worth (valuation)?
Lantern's valuation is estimated at $1.0B based on funding round data.
Can I buy Lantern stock?
Lantern shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lantern's last funding round?
Lantern's most recent funding round was Growth Equity on March 19, 2026.
Who are the main investors in Lantern?
Key investors in Lantern include Redmile Group, Morgan Health, Dundon Capital Partners, Serent Capital, Echo Health Ventures.
Will Lantern IPO soon?
No public IPO plans have been announced for Lantern.
How can I track Lantern secondary market activity?
Caplight tracks bids, offers, and trades in Lantern's shares on secondary markets.